Categories: NewsSeniors

Sienna Announces April Dividend

MARKHAM, Ontario, April 14, 2023 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of April 2023, representing $0.936 per Common Share on an annualized basis.

The dividend will be payable on May 15, 2023 to shareholders of record as at April 28, 2023.  

The Company’s dividends are designated as eligible dividends for Canadian tax purposes in accordance with subsection 89(14) of the Income Tax Act (Canada), and any applicable corresponding provincial and territorial legislation.

About Sienna Senior Living

Sienna Senior Living Inc. (TSX:SIA) offers a full range of seniors’ living options, including independent living and assisted living under its Aspira retirement brand, long-term care, and specialized programs and services. Sienna’s approximately 12,000 employees are passionate about cultivating happiness in daily life. For more information, please visit  www.siennaliving.ca.

For further information, please contact:
David Hung
Chief Financial Officer & Executive Vice President
(905) 489-0258
david.hung@siennaliving.ca

Staff

Recent Posts

ZYUS Life Sciences Announces LIFE Offering of a minimum of C$15 Million and maximum of C$16 Million of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON,…

13 seconds ago

Mixie Technologies, Inc. (PHCG) Announces CES Picks Award Recognition for HoloTwin LLC

Recognition by TechRadar Pro at CES 2026 underscores the strategic rationale behind Mixie’s strategic investment…

19 seconds ago

HealthEquity Announces Fiscal Year 2027 Outlook Presentation at J.P. Morgan Healthcare Conference

DRAPER, Utah, Jan. 12, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the…

24 seconds ago

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

Experienced medical executive advances to permanent role following successful leadership as Interim CMOSEATTLE and VANCOUVER,…

34 seconds ago

ACCENT DATA PRESENTED AT 2026 ASCO GASTROINTESTINAL CANCER SYMPOSIUM

HIGHLIGHTS Results from the Phase 2a ACCENT trial in pancreatic cancer have been presented at…

43 seconds ago